FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

377271004: Product containing precisely codeine phosphate 30 milligram and paracetamol 300 milligram/1 each conventional release oral tablet (clinical drug)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3501625017 Acetaminophen 300 mg and codeine phosphate 30 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3681489018 Codeine phosphate 30 mg and paracetamol 300 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3681490010 Product containing precisely codeine phosphate 30 milligram and paracetamol 300 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
4744531000005117 paracetamol 300 mg +codeinphosphat 30 mg tablet da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Codeine phosphate 30 mg and paracetamol 300 mg oral tablet Is a codeinphosphatprodukt false Inferred relationship Some
Codeine phosphate 30 mg and paracetamol 300 mg oral tablet Is a Product containing paracetamol (medicinal product) false Inferred relationship Some
Codeine phosphate 30 mg and paracetamol 300 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Codeine phosphate false Inferred relationship Some
Codeine phosphate 30 mg and paracetamol 300 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Non-opioid analgesic (substance) false Inferred relationship Some
Codeine phosphate 30 mg and paracetamol 300 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Morphinan opioid false Inferred relationship Some
Codeine phosphate 30 mg and paracetamol 300 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Codeine (substance) false Inferred relationship Some
Codeine phosphate 30 mg and paracetamol 300 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Paracetamol false Inferred relationship Some
Codeine phosphate 30 mg and paracetamol 300 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Central nervous system agent (substance) false Inferred relationship Some
Codeine phosphate 30 mg and paracetamol 300 mg oral tablet Is a Acetaminophen + codeine phosphate false Inferred relationship Some
Codeine phosphate 30 mg and paracetamol 300 mg oral tablet Has manufactured dose form A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. false Inferred relationship Some
Codeine phosphate 30 mg and paracetamol 300 mg oral tablet Is a Product containing codeine and paracetamol (medicinal product) false Inferred relationship Some
Codeine phosphate 30 mg and paracetamol 300 mg oral tablet Has manufactured dose form Oral tablet true Inferred relationship Some
Codeine phosphate 30 mg and paracetamol 300 mg oral tablet Is a Product containing paracetamol in oral dose form (medicinal product form) false Inferred relationship Some
Codeine phosphate 30 mg and paracetamol 300 mg oral tablet Is a Codeine-containing product in oral dose form false Inferred relationship Some
Codeine phosphate 30 mg and paracetamol 300 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Codeine phosphate false Inferred relationship Some 1
Codeine phosphate 30 mg and paracetamol 300 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. Codeine phosphate true Inferred relationship Some 1
Codeine phosphate 30 mg and paracetamol 300 mg oral tablet Has presentation strength numerator value 30 false Inferred relationship Some 1
Codeine phosphate 30 mg and paracetamol 300 mg oral tablet This attribute specifies the numerator unit for the presentation strength of a product. mg true Inferred relationship Some 1
Codeine phosphate 30 mg and paracetamol 300 mg oral tablet Has presentation strength denominator value en false Inferred relationship Some 1
Codeine phosphate 30 mg and paracetamol 300 mg oral tablet This attribute specifies the denominator unit for the presentation strength of a product. Tablet (unit of presentation) true Inferred relationship Some 1
Codeine phosphate 30 mg and paracetamol 300 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Paracetamol false Inferred relationship Some 2
Codeine phosphate 30 mg and paracetamol 300 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. Paracetamol true Inferred relationship Some 2
Codeine phosphate 30 mg and paracetamol 300 mg oral tablet Has presentation strength numerator value 300 false Inferred relationship Some 2
Codeine phosphate 30 mg and paracetamol 300 mg oral tablet This attribute specifies the numerator unit for the presentation strength of a product. mg true Inferred relationship Some 2
Codeine phosphate 30 mg and paracetamol 300 mg oral tablet Has presentation strength denominator value en false Inferred relationship Some 2
Codeine phosphate 30 mg and paracetamol 300 mg oral tablet This attribute specifies the denominator unit for the presentation strength of a product. Tablet (unit of presentation) true Inferred relationship Some 2
Codeine phosphate 30 mg and paracetamol 300 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. Paracetamol false Inferred relationship Some 1
Codeine phosphate 30 mg and paracetamol 300 mg oral tablet Has presentation strength numerator value 300 false Inferred relationship Some 1
Codeine phosphate 30 mg and paracetamol 300 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. Codeine phosphate false Inferred relationship Some 2
Codeine phosphate 30 mg and paracetamol 300 mg oral tablet Has presentation strength numerator value 30 false Inferred relationship Some 2
Codeine phosphate 30 mg and paracetamol 300 mg oral tablet Is a Codeine- and paracetamol-containing product in oral dose form false Inferred relationship Some
Codeine phosphate 30 mg and paracetamol 300 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). Codeine phosphate false Inferred relationship Some 2
Codeine phosphate 30 mg and paracetamol 300 mg oral tablet Has unit of presentation Tablet (unit of presentation) true Inferred relationship Some
Codeine phosphate 30 mg and paracetamol 300 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). Paracetamol false Inferred relationship Some 1
Codeine phosphate 30 mg and paracetamol 300 mg oral tablet Count of base of active ingredient to false Inferred relationship Some
Codeine phosphate 30 mg and paracetamol 300 mg oral tablet Is a Product containing only codeine and paracetamol in oral dose form (medicinal product form) true Inferred relationship Some
Codeine phosphate 30 mg and paracetamol 300 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). Codeine phosphate true Inferred relationship Some 1
Codeine phosphate 30 mg and paracetamol 300 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). Paracetamol true Inferred relationship Some 2
Codeine phosphate 30 mg and paracetamol 300 mg oral tablet Plays role Antitussive therapeutic role (role) false Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start